Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

st. mary's medical park pharmacy - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 15 mg - meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis [ see clinical studies ( 14.1) ]. meloxicam tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis [ see clinical studies ( 14.1) ]. meloxicam tablets are indicated for relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients who weigh ≥60 kg [ see dosage and administration ( 2.4) and clinical studies ( 14.2) ]. meloxicam tablets are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product [ see warnings and precautions ( 5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reac

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

it3 medical llc - ketorolac tromethamine (unii: 4eve5946bq) (ketorolac - unii:yzi5105v0l) - carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). ketorolac tromethamine is indicated for the short-term (≤5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. therapy should always be initiated with iv or im dosing of ketorolac tromethamine, and oral ketorolac tromethamine is to be used only as continuation treatment, if necessary. the total combined duration of use of ketorolac tromethamine injection, and oral ketorolac tromethamine is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see warnings, precautions, dosage and administration , and adverse reactions ). patients should be switched to alternative analgesics a

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

st. mary's medical park pharmacy - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis [ see clinical studies ( 14.1) ]. meloxicam tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis [ see clinical studies ( 14.1) ]. meloxicam tablets are indicated for relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients who weigh ≥60 kg [ see dosage and administration ( 2.4) and clinical studies ( 14.2) ]. meloxicam tablets are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product [ see warnings and precautions ( 5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reac

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

green pharmaceuticals inc - atropa belladonna (unii: wqz3g9pf0h) (atropa belladonna - unii:wqz3g9pf0h), ephedra distachya flowering twig (unii: r55vq87dp3) (ephedra distachya flowering twig - unii:r55vq87dp3), histamine dihydrochloride (unii: 3poa0q644u) (histamine - unii:820484n8i3), goldenseal (unii: zw3z11d0jv) (goldenseal - unii:zw3z11d0jv), potassium dichromate (unii: t4423s18fm) (dichromate ion - unii:9lky4bfn2v), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), teucrium marum (un - temporarily relieves symptoms of non-apneic snoring. individual results may vary. chew or suck one tablet 30 minutes before bedtime and repeat at bedtime. when continuous improvement is noticed, you may start using every other night until no longer needed. in some cases, regular use may be more effective. for maximum results, use in conjunction with snorestop naso spray. may be used up to 4 times per day. please discard 6 months after first use.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

green pharmaceuticals inc - atropa belladonna (unii: wqz3g9pf0h) (atropa belladonna - unii:wqz3g9pf0h), ephedra distachya flowering twig (unii: r55vq87dp3) (ephedra distachya flowering twig - unii:r55vq87dp3), histamine dihydrochloride (unii: 3poa0q644u) (histamine - unii:820484n8i3), goldenseal (unii: zw3z11d0jv) (goldenseal - unii:zw3z11d0jv), potassium dichromate (unii: t4423s18fm) (dichromate ion - unii:9lky4bfn2v), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), teucrium marum (un - temporarily relieves symptoms of non-apneic snoring. individual results may vary. adults: chew one tablet 30 mins before bedtime and repeat at bedtime. do not take with water. use 30 mins apart from any food, water, or medicine. please allow 3-5 days for initial treatment. for maximum results, use in conjunction with the snorestop nasal spray. if symptoms improve after 14 days you may reduce to one tablet at bedtime. nux vom,4x,6x hpus……………………………. helps open constricted pharynx belladonna 6x hpus………………………………. helps decongest enlarged tonsils ephedra vulg. 6x hpus……………………………helps relieve congestion hydrastis 6x, hpus…………………………………helps decongest swollen tongue kali bic. 6x hpus……………………………………. helps relieve stuffy nose teucrium mar. 6x hpus…………………………. helps open air passages histaminium hydrochlor. 12x hpus…………helps regulate histamine level

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

viatris limited - pancreatin 60.12mg (3,600 ph. eur. u/amylase, 5,000 ph. eur. u/lipase and 200 ph. eur. u/protease) - modified release granules - 60.12 mg - active: pancreatin 60.12mg (3,600 ph. eur. u/amylase, 5,000 ph. eur. u/lipase and 200 ph. eur. u/protease) excipient: cetyl alcohol dimeticone hypromellose phthalate macrogol 4000 triethyl citrate - for treatment of conditions associated with pancreatic exocrine insufficiency, such as: cystic fibrosis, chronic pancreatitis, post-pancreatectomy, post-gastrointestinal bypass surgery, e.g. billroth ii, gastroenterostomy; ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

sasa cosmetics - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp) - purpose: sunscreen uses: helps prevent sunburn -- if used as directed with other sun protection measures ( see directions), decreases the risk of skin cancer and early skin aging caused by the sun

Belgia - inglise - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bayer sa-nv - gestodene 60 µg (light yellow tablet); ethinylestradiol 15 µg (light yellow tablet); placebo (white tablet) - film-coated tablet - 60 µg - 15 µg - ethinylestradiol 15 µg; gestodene 60 µg; placebo - gestodene and ethinylestradiol

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

trifluent pharma llc - calcipotriene (unii: 143nq3779b) (calcipotriene - unii:143nq3779b) - calcipotriene foam should not be used by patients with known hypercalcemia. calcipotriene foam is indicated for the topical treatment of plaque psoriasis of the scalp and body in adults and pediatric patients 4 years of age and older. risk summary although there are no available data on the drug- associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes in pregnant women exposed to calcipotriene foam, systemic exposure to calcipotriene is likely to be low [see clinical pharmacology ( 12.2, 12.3)] . in animal reproduction studies, oral administration of calcipotriene to pregnant rats and rabbits during the period of organogenesis resulted in an increased incidence of minor skeletal abnormalities, including enlarged fontanelles and extra ribs in rats and an increased incidence of minor skeletal abnormalities, including incomplete ossification of pubic bones and forelimb phalanges in rabbits (see data) . the available data do not allow the calculation of rel

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

stratford care usa, inc. - chlorhexidine gluconate (unii: mor84mud8e) (chlorhexidine - unii:r4ko0dy52l), ketoconazole (unii: r9400w927i) (ketoconazole - unii:r9400w927i) - antibacterial and antifungal keto-c® xl wipes contain an antiseptic (antibacterial and antifungal) solution for the topical management of skin conditions that are responsive to chlorhexidine and ketoconazole. keto-c® xl wipes can be used for the antiseptic cleansing of face folds, finger folds, as well as underarms and groin areas.